Barka EA, Vatsa P, Sanchez L, Gaveau Vaillant N, Jacquard C, Klenk HP
A PRAGMATIC PATH TO A GREENER FUTURE The GLP-1 era is unfolding at a rapid pace, reshaping treatment landscapes for obesity and metabolic diseases
All these properties make MB a promising drug candidate for brain diseases treatment
BMI of 30 or higher (obesity) BMI of 27 or higher with a weight-related condition (hypertension, type 2 diabetes, high cholesterol, sleep apnea) Have tried diet and exercise without sustained results Are not pregnant, nursing, or planning pregnancy Have no personal or family history of medullary thyroid cancer or MEN2 syndrome Not sure if you qualify
Those things feel easier to do, and there's a payoff